{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:13Z","timestamp":1772166193714,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00819-4","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T11:54:54Z","timestamp":1766404494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 3 von Willebrand disease in Ethiopia: a comprehensive literature review and report of the first three cases"],"prefix":"10.1186","volume":"23","author":[{"given":"Gashaw","family":"Arega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elezer Berhanu","family":"Zewde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir Mohamed","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Zerihun","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinsae Yidnekachew","family":"Tamiru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Telila Kumneger","family":"Belisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melat Shewabera","family":"Ejersa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andebet Sisay","family":"Deress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"819_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/ANNUREV.BIOCHEM.67.1.395","volume":"67","author":"JE Sadler","year":"1998","unstructured":"Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395\u2013424. https:\/\/doi.org\/10.1146\/ANNUREV.BIOCHEM.67.1.395.","journal-title":"Annu Rev Biochem"},{"key":"819_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/J.1538-7836.2006.02146.X\/ASSET\/AE31FDE2-0E5E-4B60-9AAA-CCDE1E75FB9D\/MAIN.ASSETS\/JTH_2146_F2.JPG","volume":"4","author":"JE Sadler","year":"2006","unstructured":"Sadler JE, Budde U, Eikenboom JCJ, Favaloro EJ, Hill FGH, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB. Update on the pathophysiology and classification of von Willebrand disease: A report of the subcommittee on von Willebrand factor. J Thromb Haemost. 2006;4:2103\u201314. https:\/\/doi.org\/10.1111\/J.1538-7836.2006.02146.X\/ASSET\/AE31FDE2-0E5E-4B60-9AAA-CCDE1E75FB9D\/MAIN.ASSETS\/JTH_2146_F2.JPG.","journal-title":"J Thromb Haemost"},{"key":"819_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/ANNUREV.CB.06.110190.001245\/CITE\/REFWORKS","volume":"6","author":"DD Wagner","year":"1990","unstructured":"Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217\u201342. https:\/\/doi.org\/10.1146\/ANNUREV.CB.06.110190.001245\/CITE\/REFWORKS.","journal-title":"Annu Rev Cell Biol"},{"key":"819_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/BEHA.2001.0139","volume":"14","author":"JCJ Eikenboom","year":"2001","unstructured":"Eikenboom JCJ. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Best Pract Res Clin Haematol. 2001;14:365\u201379. https:\/\/doi.org\/10.1053\/BEHA.2001.0139.","journal-title":"Best Pract Res Clin Haematol"},{"key":"819_CR5","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/jth.14886","volume":"18","author":"A Tosetto","year":"2020","unstructured":"Tosetto A, Badiee Z, Baghaipour MR, Baronciani L, Battle J, Berntorp E, Bod\u00f3 I, Budde U, Castaman G, Eikenboom JCJ, Eshghi P, Ettorre C, Goodeve A, Goudemand J, Hay CRM, Hoorfar H, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Mannucci PM, Mazzucconi MG, Morfini M, Oldenburg J, Peake I, Parra R, L\u00f2pez F, Peyvandi R, Schneppenheim A, Tiede G, Toogeh M, Trossaert O, Zekavat EMK, Zetterberg AB, Federici. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: results from 3WINTERS-IPS, an international and collaborative cross-sectional study. J Thromb Haemost. 2020;18:2145\u201354. https:\/\/doi.org\/10.1111\/jth.14886.","journal-title":"J Thromb Haemost"},{"key":"819_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jth.12130","volume":"11","author":"M Bowman","year":"2013","unstructured":"Bowman M, Tuttle A, Notley C, Brown C, Tinlin S, Deforest M, Leggo J, Blanchette VS, Lillicrap D, James P. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles. J Thromb Haemost. 2013;11:512\u201320. https:\/\/doi.org\/10.1111\/jth.12130.","journal-title":"J Thromb Haemost"},{"key":"819_CR7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/jth.15713","volume":"20","author":"PA Christopherson","year":"2022","unstructured":"Christopherson PA, Haberichter SL, Flood VH, Perry CL, Sadler BE, Bellissimo DB, Di Paola J, Montgomery RR, Abshire T, Weiler H, Lillicrap D, James P, O\u2019Donnell J, Ng C, Bennett C, Sidonio R, Manco-Johnson M, Journeycake J, Zia A, Lusher J, Rajpurkar M, Shapiro A, Lentz S, Gill J, Leissinger C, Ragni M, Tarantino M, Roberts J, Hord J, Strouse J, Ma A, Valentino L, Boggio L, Sharathkumar A, Gruppo R, Kerlin B, Kulkarni R, Green D, Hoots K, Brown D, Mahoney D, Mathias L, Bedros A, Diamond C, Neff A, DiMichele D, Giardina P, Cohen A, Paidas M, Werner E, Matsunaga A, Shafer F, Konkle B, Cuker A, Kouides P, Stein D. Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program. J Thromb Haemost. 2022;20:1576\u201388. https:\/\/doi.org\/10.1111\/jth.15713.","journal-title":"J Thromb Haemost"},{"key":"819_CR8","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1182\/BLOODADVANCES.2020003397","volume":"5","author":"L Baronciani","year":"2021","unstructured":"Baronciani L, Peake I, Schneppenheim R, Goodeve A, Ahmadinejad M, Badiee Z, Baghaipour MR, Benitez O, Bod\u00f3 I, Budde U, Cairo A, Castaman G, Eshghi P, Goudemand J, Hassenpflug W, Hoorfar H, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Fernandez MFL, Mannucci PM, Marino R, Nik\u0161i\u0107 N, Oyen F, Santoro C, Tiede A, Toogeh G, Tosetto A, Trossaert M, Zetterberg EMK, Eikenboom J, Federici AB, Peyvandi F. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. Blood Adv. 2021;5:2987\u20133001. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2020003397.","journal-title":"Blood Adv"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","volume":"30","author":"L Baronciani","year":"2003","unstructured":"Baronciani L, Cozzi G, Canciani MT, Peyvandi F, Srivastava A, Federici AB, Mannucci PM. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis. 2003;30:264\u201370. https:\/\/doi.org\/10.1016\/S1079-9796(03)00033-0.","journal-title":"Blood Cells Mol Dis"},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1160\/TH12-04-0244\/ID\/JR0244-5\/BIB","volume":"108","author":"EM de Wee","year":"2012","unstructured":"de Wee EM, Sanders YV, Mauser-Bunschoten EP, van der Bom JG, Degenaar-Dujardin MEL, Eikenboom J, de Goede-Bolder A, Laros-van Gorkom BAP, Meijer K, Hamuly\u00e1k K, Nijziel MR, Fijnvandraat K, Leebeek FWG. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost. 2012;108:683\u201392. https:\/\/doi.org\/10.1160\/TH12-04-0244\/ID\/JR0244-5\/BIB.","journal-title":"Thromb Haemost"},{"key":"819_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/J.1365-2516.2009.02025.X","volume":"15","author":"AD Metjian","year":"2009","unstructured":"Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA, Boyd M, Roy G, Forman E, Marandola J, Homans AC, Granat M, Lusher J, Fleming P, DiMichele D, Goldberg I, Saidi P, Schwartz R, Desposito F, Joseph D, Kouides PA, Franco JL, Coyle T, Dhar N, Porter J, Frank M, Lipton R, Bosch M, Holmberg RP, Menza L, Cohen A, White E, Guerrera M, Guelcher C, Kessler C, Jacobs H, Massey G, Nolte M, Werner E, Stewart K, Ragni M, Jaworski K, Rogers JS, Webber S, Jubelirer S, Arden D, Casella J, Underland T, Panckeri K, Palumbo L, Sabio H, Smith A, Sharma V, Ashby P, Radulescu V, Hanna W, Zimmerman C, Neff A, Hudson MG, Reiss U, Grant R, Key N, Nielsen B, Dunn A, Gutting K, Watts R, Noa MC, Abshire T, Bryant C, Ameri A, Crenshaw V, Kuriakose P, Lambing A, Heggie G, Kovats-Bell S, Inoue S, Ruff JA, Mitchell D, Sandon-Kleiboer E, Kraut E, Witkoff L, Gruppo R, Chambers A, Kerlin B, Lupia C, French J, Hibner S, Shapiro A, May S, Alexander S, Hopewell S, Bockenstedt P, Pipe S, Mathis D, Zakarija A, Harris S, Thompson A, Allen GA, Brummel AT, Tarantino M, Riedel A, Reding M, Curoe S, Pruthi R, Schmidt K, Kralovetz K, Charles J, Diamond C, Drozdowicz P, Gill JC, Haar J, Hoots WK, Gonzalez V, Leissinger C, Schmidt CV, Stine K, Eckert G, Sexauer C, Kiplinger F, Amerson P, Johnson E, Buchanan G, Torres R, DiPaola J, Lammer M, Wicklund B, Nelson D, Haire WD, Hanlon E, Manco-Johnson M, Geraghty S, Yaish H, Green J, Young G, McGinty K, Herbst K, Glass C, Glader B, Zoland JM, Medeiros D, Omatsu DA, Ducore J, Herr M, Koerper M, Karp S, Lovejoy AE, Farrow K, Ewing N, Pullens L, Meadows L, Tackney A, Mignacca R, Patterson F, Bernstein J, Berkowitz B, Thompson AR. Haemophilia. 2009;15:918\u201325. https:\/\/doi.org\/10.1111\/J.1365-2516.2009.02025.X. C. Brower, M. Recht, K. Granger, L. Schulz, A. Stewart, Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.","journal-title":"Haemophilia"},{"key":"819_CR12","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/JTH.12672","volume":"12","author":"VS Blanchette","year":"2014","unstructured":"Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12:1935\u20139. https:\/\/doi.org\/10.1111\/JTH.12672.","journal-title":"J Thromb Haemost"},{"key":"819_CR13","doi-asserted-by":"publisher","unstructured":"Sood SL, Cuker A, Wang C, Metjian AD, Chiang EY, Soucie JM, Konkle BA, Haemophilia. 2013;19:595. https:\/\/doi.org\/10.1111\/HAE.12119.","DOI":"10.1111\/HAE.12119"},{"key":"819_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/IJLH.12345","volume":"37","author":"JC Roberts","year":"2015","unstructured":"Roberts JC, Flood VH. Laboratory diagnosis of von Willebrand disease. Int J Lab Hematol. 2015;37:11\u20137. https:\/\/doi.org\/10.1111\/IJLH.12345.","journal-title":"Int J Lab Hematol"},{"key":"819_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/09537104.2019.1581922","volume":"31","author":"T Szanto","year":"2020","unstructured":"Szanto T, Nummi V, Jouppila A, Brinkman HJM, Lassila R. Platelets compensate for poor thrombin generation in type 3 von Willebrand disease. Platelets. 2020;31:103\u201311. https:\/\/doi.org\/10.1080\/09537104.2019.1581922.","journal-title":"Platelets"},{"key":"819_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.BLRE.2016.08.003","volume":"31","author":"LL Swystun","year":"2017","unstructured":"Swystun LL, James PD. Genetic diagnosis in hemophilia and von Willebrand disease. Blood Rev. 2017;31:47\u201356. https:\/\/doi.org\/10.1016\/J.BLRE.2016.08.003.","journal-title":"Blood Rev"},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/rth2.12064","volume":"2","author":"DA Keesler","year":"2017","unstructured":"Keesler DA, Flood VH. Current issues in diagnosis and treatment of von Willebrand disease. Res Pract Thromb Haemost. 2017;2:34\u201341. https:\/\/doi.org\/10.1002\/rth2.12064.","journal-title":"Res Pract Thromb Haemost"},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/ASHEDUCATION-2017.1.379","volume":"2017","author":"R Sharma","year":"2017","unstructured":"Sharma R, Flood VH. Advances in the diagnosis and treatment of von Willebrand disease. Hematology. 2017;2017:379\u201384. https:\/\/doi.org\/10.1182\/ASHEDUCATION-2017.1.379.","journal-title":"Hematology"},{"key":"819_CR19","doi-asserted-by":"publisher","unstructured":"Abshire T.C., Federici A.B., Alv\u00e1rez M.T., Bowen J., Carcao M.D., Cox Gill J., Key N.S., Kouides P.A., Kurnik K., Lail A.E., Leebeek F.W.G., Makris M., Mannucci P.M., Winikoff R., Berntorp E. Prophylaxis in severe forms of von willebrand\u2019s disease: results from the von Willebrand disease prophylaxis network (VWD PN). Haemophilia. 2013;19:76\u201381. https:\/\/doi.org\/10.1111\/J.1365-2516.2012.02916.X.","DOI":"10.1111\/J.1365-2516.2012.02916.X"},{"key":"819_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/jth.14313","volume":"17","author":"F Peyvandi","year":"2019","unstructured":"Peyvandi F, Mamaev A, Wang JD, Stasyshyn O, Timofeeva M, Curry N, Cid AR, Yee TT, Kavakli K, Castaman G, Sytkowski A. Phase 3 study of Recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery. J Thromb Haemost. 2019;17:52\u201362. https:\/\/doi.org\/10.1111\/jth.14313.","journal-title":"J Thromb Haemost"},{"key":"819_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/HAE.13451","volume":"24","author":"HCAM Hazendonk","year":"2018","unstructured":"Hazendonk HCAM, Heijdra JM, de Jager NCB, Veerman HC, Boender J, van Moort I, Math\u00f4t RAA, Meijer K, Laros-van Gorkom BAP, Eikenboom J, Fijnvandraat K, Leebeek FWG, Cnossen MH. Analysis of current perioperative management with Haemate\u00ae P\/Humate P\u00ae in von Willebrand disease: identifying the need for personalized treatment. Haemophilia. 2018;24:460\u201370. https:\/\/doi.org\/10.1111\/HAE.13451.","journal-title":"Haemophilia"},{"key":"819_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/HAE.13106","volume":"23","author":"A Srivastava","year":"2017","unstructured":"Srivastava A, Serban M, Werner S, Schwartz BA, Kessler CM, Alkindi S, Apte SJ, Castaman G, Gill JC, Hellmann A, Kavakli K, Kouides PA, Kuriakose P, Lissitchkov T, Ma A, Mahlangu J, Morfini M, Neufeld EJ, Peyvandi F, Reding M, Rodriguez NI, Ross C, Rusen L, Shapiro A, Uscatescu V, Windyga J, Zulfikar B. Efficacy and safety of a VWF\/FVIII concentrate (wilate\u00ae) in inherited von Willebrand disease patients undergoing surgical procedures. Haemophilia. 2017;23:264\u201372. https:\/\/doi.org\/10.1111\/HAE.13106.","journal-title":"Haemophilia"},{"key":"819_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1182\/BLOOD-2012-10-462085","volume":"122","author":"PD James","year":"2013","unstructured":"James PD, Lillicrap D, Mannucci PM. Alloantibodies in von Willebrand disease. Blood. 2013;122:636\u201340. https:\/\/doi.org\/10.1182\/BLOOD-2012-10-462085.","journal-title":"Blood"},{"key":"819_CR24","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1182\/BLOODADVANCES.2024013095","volume":"8","author":"CL Perry","year":"2024","unstructured":"Perry CL, Christopherson PA, Agostini TA, Haberichter SL, Montgomery RR, Flood VH. Prevalence and characterization of anti-VWF antibodies in a population of patients with type 3 VWD. Blood Adv. 2024;8:5051\u201361. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2024013095.","journal-title":"Blood Adv"},{"key":"819_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/MBC.0B013E3280100D1E","volume":"17","author":"M Franchini","year":"2006","unstructured":"Franchini M, Veneri D, Lippi G. The use of Recombinant activated factor VII in congenital and acquired von Willebrand disease. Blood Coagul Fibrinolysis. 2006;17:615\u20139. https:\/\/doi.org\/10.1097\/MBC.0B013E3280100D1E.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"819_CR26","doi-asserted-by":"publisher","first-page":"073","DOI":"10.1055\/S-0044-1787662\/ID\/JR03236-16\/BIB","volume":"51","author":"AC Giuffrida","year":"2024","unstructured":"Giuffrida AC, Siboni SM, Baronciani L, Poli G, Gandini G, Peyvandi F. Emicizumab in type 3 von Willebrand disease: report of a case with an alloantibody and literature review. Semin Thromb Hemost. 2024;51:073\u201380. https:\/\/doi.org\/10.1055\/S-0044-1787662\/ID\/JR03236-16\/BIB.","journal-title":"Semin Thromb Hemost"},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MBC.0000000000001298","volume":"35","author":"FI Lemaistre","year":"2024","unstructured":"Lemaistre FI, Chiang E, Streiff MB, Yui JC. Efficacy of Emicizumab therapy in two adult patients with type 3 von Willebrand disease. Blood Coagul Fibrinolysis. 2024;35:206\u20138. https:\/\/doi.org\/10.1097\/MBC.0000000000001298.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"819_CR28","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/BLOODADVANCES.2018017418","volume":"2","author":"M Lavin","year":"2018","unstructured":"Lavin M, Aguila S, Dalton N, Nolan M, Byrne M, Ryan K, White B, O\u2019Connell NM, O\u2019Sullivan JM, Di Paola J, James PD. O\u2019Donnell, significant gynecological bleeding in women with low von Willebrand factor levels. Blood Adv. 2018;2:1784\u201391. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2018017418.","journal-title":"Blood Adv"},{"key":"819_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1055\/S-2005-922231","volume":"31","author":"PM Mannucci","year":"2005","unstructured":"Mannucci PM. Management of von Willebrand disease in developing countries. Semin Thromb Hemost. 2005;31:602\u20139. https:\/\/doi.org\/10.1055\/S-2005-922231.","journal-title":"Semin Thromb Hemost"},{"key":"819_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/J.SEMINHEMATOL.2004.09.007","volume":"42","author":"A Srivastava","year":"2005","unstructured":"Srivastava A. Von Willebrand disease in the developing world. Semin Hematol. 2005;42:36\u201341. https:\/\/doi.org\/10.1053\/J.SEMINHEMATOL.2004.09.007.","journal-title":"Semin Hematol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00819-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00819-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00819-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:59:10Z","timestamp":1767041950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-025-00819-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00819-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6866302\/v1","asserted-by":"object"}]},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from both the child\u2019s parents for cases one and three and the adult patient for case two, allowing for the publication of the paper and its accompanying information. The editor-in-chief of this journal can review a copy of the written consent form upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}